Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 66 OF 87 | DISPLAYING 976 - 990 OF 1293 RESULTS

    Yu P.Y. et al., A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas., [Epub ahead of print]., Lab Invest., Feb 15, 2016

    Yu Z. et. al., Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells., [Epub ahead of print]., Oncotarget, Feb 15, 2016

    Itineang T. et al., Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the Tumor., [Epub ahead of print]., Frontiers in Surgery, Feb 09, 2016

    Beltran H. et al., Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer., [Epub ahead of print]., Nat. Med., Feb 08, 2016

    Braunstein M. et al., Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer., [Epub ahead of print]., Breast Can Res., Feb 06, 2016

    Pinto J.A. et al., A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease., [Epub ahead of print]., Nature Genomic Med., Feb 03, 2016

    Arques O. et al., Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer., [Epub ahead of print]., Clin. Can. Res., Feb 01, 2016

    Bhise N.S. et al., MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients., [Epub ahead of print]., Frontiers in Pharmacology, Jan 28, 2016

    Flynn A. et al., Pheo-type: a diagnostic gene-expression assay for the classification of pheochromocytoma and paraganglioma., [Epub ahead of print]., J Clin Endocrinol Metab. , Jan 21, 2016

    Yoshimura T. et al., Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells, [Epub ahead of print]., Frontiers in Immunology, Jan 20, 2016

    Rovira J. et al., MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome., [Epub ahead of print]., Clin. Can. Res., Jan 20, 2016

    Marcotte R. et al., Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance., [Epub ahead of print]., Cell, Jan 14, 2016

    Linge A. et al., Low CSC marker expression and low hypoxia identify good prognosis subgroups in HPV(-)HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG., [Epub ahead of print]., Clin. Can. Res., Jan 11, 2016

    Liu M.C. et al., PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance), [Epub ahead of print]., Breast Cancer, Jan 06, 2016

    Flinn I.W. et. al., A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)., [Epub ahead of print]., Eur. J. Can, Dec 20, 2015